Skip to main content
NIH funding notice PA-18-688

Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)

Closed on May 7, 2021.

Posted
March 1, 2018
Close date
May 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $549,395 in first-year total cost, median $549,395.

Most frequent study sections

  1. Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]1

Most frequent institutions

  1. CHILDREN'S MERCY HOSP (KANSAS CITY, MO)1
Competing awards under PA-18-688 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma1R01HD100545-01JONES, BRIDGETTE L.CHILDREN'S MERCY HOSP (KANSAS CITY, MO), MO$549,395LCMI

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.